Streetbeat News

Analyst Ratings

AFL

TD Cowen has initiated coverage on Aflac with a Hold rating and set a price target of $102.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:16 am

MET

TD Cowen has initiated coverage on MetLife with a Buy rating and set a price target of $97, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:13 am

PRI

TD Cowen has initiated coverage on Primerica with a Buy rating and set a price target of $314, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:09 am

CRBG

TD Cowen has initiated coverage on Corebridge Financial with a Buy rating and set a price target of $35, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:59 am

GL

TD Cowen has initiated coverage on Globe Life (NYSE:GL) with a Buy rating and set a price target of $150.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:57 am

ALAB

Needham analyst Quinn Bolton has reiterated a Buy rating on Astera Labs (NASDAQ:ALAB) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:51 am

RDDT

Needham analyst Laura Martin has maintained a Buy rating on Reddit (NYSE:RDDT) and raised the price target from $75 to $85.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:46 am

DAWN

Needham analyst Ami Fadia has maintained a Buy rating on Day One Biopharmaceutical (NASDAQ:DAWN) and raised the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:43 am

NARI

Needham analyst Mike Matson has reiterated a Hold rating on Inari Medical (NASDAQ:NARI).

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:40 am

ZETA

Needham analyst Ryan MacDonald has reiterated a Buy rating on Zeta Global Holdings (NYSE:ZETA) and maintained a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:36 am